date:Jun 13, 2012
ocysteinate supplementation could be used as an adjunct therapy for those with established diabetes. Furthermore, it might delay or prevent the development of diabetes in subjects with insulin resistance or prediabetes.
Reinvigorating the blood sugar market
The ingredient was launched in 2011 and was in development for over five years, said the California-based company. The chromium is in the form of chromium dinicocysteinate, which is a combination of chromium, niacin and L-cysteine.
At the